Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$407,000,970
+$80,736,742 QoQ
Shares Held
7,001,565
+24.7% QoQ
Ownership
4.71%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#6
of 329 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 0%
Shared 86%
None 14%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,994,233,945 across 206 Biotechnology names. PCVX ranks #12 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,247,658 | $1,613,209,155 | |
| 2 | ARGX |
Argenx SE
|
930,548 | $863,334,513 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,270,087 | $791,950,042 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,843,415 | $719,794,757 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,110,407 | $635,295,816 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
7,651,415 | $606,680,693 | |
| 7 | CYTK |
Cytokinetics Inc
|
6,931,770 | $590,517,483 | |
| 8 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
825,714 | $443,367,129 |
All Filings in PCVX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $407,000,970 | 7,001,565 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $326,264,228 | 5,614,597 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $275,285,541 | 5,966,310 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $181,280,407 | 5,032,771 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $161,080,674 | 4,954,804 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $242,303,274 | 6,416,930 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $363,786,817 | 4,444,012 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $515,786,893 | 4,513,756 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $346,822,410 | 4,593,066 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $336,042,162 | 4,919,370 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $278,324,572 | 4,431,920 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $234,442,333 | 4,598,712 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $221,294,673 | 4,431,211 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $121,407,986 | 3,239,274 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $169,173,063 | 3,528,114 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $41,974,104 | 1,748,921 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,811,848 | 129,221 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $27,647,280 | 1,144,815 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $27,430,463 | 1,153,025 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $26,339,665 | 1,038,221 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $19,766,593 | 878,125 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $19,718,595 | 998,410 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $26,858,282 | 1,010,850 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $54,212,127 | 1,097,856 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $37,932,000 | 1,200,000 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||